Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments.
Researchers have found that galloylquinic acids extracted from the leaves of Copaifera lucens Dwyer, a tree native to Brazil and found mainly in the Atlantic Forest, can act against SARS-CoV-2 in several different ways. SARS-CoV-2 is the virus responsible for COVID-19.
The team selected this species because researchers led by Jairo Kenupp Bastos have extensive experience studying the chemistry and pharmacology of Copaifera plants. Bastos is a pharmacist and professor at the Ribeirão Preto School of Pharmaceutical Sciences at the University of São Paulo (FCFRP-USP) and coordinated the study.
Plant Compounds With Broad Biological Activity
Galloylquinic acids have already attracted scientific interest because of their wide range of reported biological effects. Previous research has found antifungal and anticancer activity in vitro and in vivo, along with broad-spectrum antiviral properties.
Derivatives of these compounds have also shown strong inhibitory effects against HIV-1 in biochemical tests and cell cultures, while displaying lower toxicity than some of the other molecules tested.
For the new study, which was supported by FAPESP, the researchers first prepared and characterized fractions from the plant leaves that were rich in galloylquinic acids. They then performed cytotoxicity tests to determine how safely the compounds could be introduced into host cells.
Testing the Compounds Against SARS-CoV-2
The team evaluated antiviral activity using plaque reduction assays, which measure how effectively antibodies or antiviral compounds can neutralize a virus. The tests showed strong activity against SARS-CoV-2.
The researchers also examined viral protein production and the way the compounds interacted with several important viral targets. These included the receptor-binding domain of the spike protein, which helps SARS-CoV-2 enter human cells, papain-like protease (PLpro), an enzyme involved in helping the virus evade host defenses, and RNA polymerase, an enzyme the virus needs to copy its genetic material and reproduce.
“This integrated approach allowed us to understand how the compounds work and how they act at the molecular level,” said Mohamed Abdelsalam, an assistant professor of pharmacognosy and natural product chemistry at the Faculty of Pharmacy at the Delta University of Science and Technology in Egypt.
A Multi-Target Attack on the Virus
The findings, published in the journal Scientific Reports, showed that galloylquinic acids had strong activity against the coronavirus variant tested. The compounds interfered with viral entry into cells, viral replication, and the production of viral proteins.
The substances also have anti-inflammatory and immunomodulatory properties, meaning they may influence how the immune system responds during infection. That effect could be especially relevant in severe cases of COVID-19, when an overly aggressive immune response can contribute to complications.
“An important aspect revealed by this information is the multi-target mechanism of the compound, which reduces the likelihood of resistance developing. This is because many current antivirals act on only one viral protein, which promotes this effect,” says Bastos.
More Testing Is Still Needed
The findings are promising, but the compounds are not yet ready to be developed into a COVID-19 treatment. Additional work will be required, including in vivo studies and clinical trials, before researchers can determine whether they could become safe and effective medicines.
Even so, the results highlight the potential value of biodiversity and natural-product research in the search for new therapeutic candidates. They also reinforce the idea that Brazil’s rich plant life could serve as an important source of molecules for future drug development.
Reference: “Bioactive galloylquinic acids from Copaifera lucens as dual inhibitors of SARS-CoV-2 Spike and RdRp proteins” by Rasha M. El-Morsi, Lamiaa A. Al-Madboly, Jairo K. Bastos, Shaimaa M. Aboukhatwa, Samah A. Nasr, Doaa A. Ghareeb, Heba A. Ramadan, Ivan Kushkevych and Mohamed A. Abd El-Salam, 2 February 2026, Scientific Reports.
DOI: 10.1038/s41598-025-25217-8
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Researcher at Russian plague laboratory dies of ‘unknown’ infection
Russian authorities have imposed "anti-epidemic measures" after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. The researcher, a 28-year-old female [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
A Surprising Brain Signal Could Explain Why Eating Less Protein Extends Lifespan
A new paper suggests that limiting protein intake triggers a coordinated response throughout the body that may help explain how protein restriction affects healthy aging. Animals respond to protein restriction, or reduced protein in [...]
Back and shoulder surgery is often worse than useless
Millions of operations should be scrapped SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on [...]
Cocaine plays with mind, hijacks brain circuit, drives increasingly rigid and repetitive behavior
Researchers have found that cocaine hijacks brain circuit, which to drive increasingly rigid and repetitive behavior. The brain circuit that normally participates in selecting natural mouth and face movements, but which becomes disproportionately engaged [...]
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a median survival of just 12-15 months, even with the best available care. Now, researchers at the [...]
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences [...]
West African scientists warn of weakening health systems and urge stronger outbreak detection
LOME, Togo (AP) — West African laboratory scientists called on governments Friday to strengthen capacity to detect disease outbreaks to avoid another major outbreak, saying health systems across the region are becoming weaker. Participants [...]
A Little-Known Protein Could Point to a New Way To Treat Alzheimer’s
A study suggests that increasing SORLA protein levels could help treat Alzheimer’s disease and other disorders involving tau protein. Increasing SORLA, a protein with a protective role in the brain, helped mice withstand damage [...]
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
